×
Home Current Archive Editorial board
Complaints and feedback News Contact
Original Scientific Articles

This is an early access version

Myocardial perfusion imaging findings and 2-year outcomes in clinically referred asymptomatic patients with type 2 diabetes

By
Siniša Stanković ,
Siniša Stanković
Contact Siniša Stanković

Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina

Dragana Šobić-Šaranović ,
Dragana Šobić-Šaranović

Faculty of Medicine, University of Belgrade , Belgrade , Serbia

Valentina Soldat-Stanković ,
Valentina Soldat-Stanković

Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina

Vera Artiko ,
Vera Artiko

Faculty of Medicine, University of Belgrade , Belgrade , Serbia

Zvezdana Rajkovača ,
Zvezdana Rajkovača

Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina

Gostimir Mikač ,
Gostimir Mikač

ZU Centar za štitnu žlijezdu , Banja Luka , Bosnia and Herzegovina

Nataša Egeljić-Mihailović ,
Nataša Egeljić-Mihailović

Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina

Tanja Iličić
Tanja Iličić

University clinical center of Republika Srpska , Banja Luka , Bosnia and Herzegovina

Editor: Adrijan Sarajlija

Abstract

Introduction. Type 2 diabetes mellitus is associated with an increased risk of coronary artery disease, which frequently remains clinically silent. Myocardial perfusion imaging with single-photon emission computed tomography is widely used for the detection of myocardial ischemia and risk stratification, but its prognostic value in asymptomatic diabetic patients remains uncertain. The aim of this prospective study was to evaluate myocardial perfusion imaging findings and 2-year cardiac outcomes in clinically referred asymptomatic patients with type 2 diabetes.
Methods. This prospective observational study included 198 consecutive outpatients referred for stressrest SPECT myocardial perfusion imaging because of intermediate clinical suspicion of coronary artery disease. The study population consisted of 98 patients with type 2 diabetes and 100 patients without diabetes. Among them, 73 participants were classified as asymptomatic based on structured clinical interviews (37 diabetic and 36 nondiabetic patients). Myocardial 
perfusion abnormalities were defined as a summed stress score ≥4, while inducible ischemia was defined as a summed difference score ≥2. Participants were followed for approximately 24 months for the occurrence of cardiac events including cardiac death, nonfatal myocardial infarction, and coronary revascularization. Eventfree survival was analyzed using Kaplan–Meier methodology.
Results. Abnormal myocardial perfusion (SSS ≥4) was detected in 18.9% of asymptomatic diabetic patients and 22.2% of asymptomatic nondiabetic patients (p = 0.727). Inducible ischemia (SDS ≥2) was present in 8.1% and 8.3% of participants, respectively (p = 0.98). During the twoyear followup period, three cardiac events occurred in the diabetic group (8.1%), including one cardiac death and two coronary revascularizations, while no events occurred in nondiabetic 
participants (p = 0.240). Kaplan–Meier analysis demonstrated no statistically significant difference in eventfree survival between diabetic and nondiabetic groups (logrank p = 0.083).
Conclusions. Myocardial perfusion abnormalities were relatively frequent in clinically referred asymptomatic patients with type 2 diabetes; however, shortterm cardiac event rates were low. These findings suggest limited prognostic value of routine myocardial perfusion imaging in unselected asymptomatic diabetic populations and support a selective approach to noninvasive testing.

Author Contributions

Conceptualization, S.S.; Investigation, S.S., D.Š., V.S., V.A., Z.R., G.M., N.E. and T.I.; Validation, S.S.; Writing – original draft, S.S., D.Š., V.S., V.A., Z.R., G.M., N.E. and T.I.; Supervision, D.Š. All authors have read and agreed to the published version of the manuscript.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.